Long bone injuries heal through the endochondral or intramembranous bone formation pathway. Unlike the endochondral pathway, which requires a cartilage precursor step, bone repair via intramembranous ossification involves direct conversion of skeletal stem and progenitor cells (SSPCS) into bone-forming osteoblasts1. Clinically, this process is relevant for bone healing in a variety of contexts, including critical size defects, stabilized fractures, cortical defects, distraction osteogenesis, trauma from tumor resections, and osseointegration of joint replacement implants2,3. Interestingly, in studies of patients with long bone fractures, 66%-82% had displaced fractures, which required fixation devices to stabilize the bone4,5. These rigidly stabilized bones primarily heal through intramembranous ossification as the broken bone ends come in direct contact with each other6,7. Yet, the mechanistic regulation of intramembranous bone regeneration remains relatively understudied compared to bone formation via the endochondral pathways. Food and Drug Administration (FDA)-approved therapies to augment bone healing are hindered by limited clinical efficacy and high costs and are associated with significant adverse effects8.
Mechanical bone marrow ablation provides a valuable model for studying intramembranous bone formation. This simple injury model allows for studying bone regeneration in the bone marrow without disrupting the cortical bone. Following BM ablation, the healing process involves distinct yet overlapping phases. The initial phase occurs in the first 1 to 5 days and involves clot formation and inflammation, where inflammatory cells and cytokines initiate healing. From days 3 to 14, the second phase is characterized by regeneration, including neovascularization, mesenchymal stem cell (MSC) migration and proliferation, osteoblastic differentiation, and woven bone formation. The final remodeling phase begins approximately 10 days after surgery, with bone tissue undergoing maturation and restructuring until the marrow is fully restored by day 569. This rapid healing timeline makes the BM ablation model ideal for studying early bone repair responses, particularly during the critical periods of inflammation, progenitor cell recruitment, and osteoblast differentiation. Using techniques like histology, flow cytometry, and quantitative µCT analysis, cellular responses and bone formation in early repair stages can be evaluated. Using the aforementioned techniques, the BM ablation model can provide insight into mechanisms of intramembranous bone regeneration and aid in identifying key therapeutic targets for enhancing bone healing.